Scuruchi, M.; Speranza, D.; Bruschetta, G.; Vaccaro, F.; Galeano, M.; Pallio, G.; Vaccaro, M.; Borgia, F.; Li Pomi, F.; Collino, M.;
et al. Protein Kinase CK2 Inhibition Represents a Pharmacological Chance for the Treatment of Skin Diseases. Int. J. Mol. Sci. 2025, 26, 5404.
https://doi.org/10.3390/ijms26115404
AMA Style
Scuruchi M, Speranza D, Bruschetta G, Vaccaro F, Galeano M, Pallio G, Vaccaro M, Borgia F, Li Pomi F, Collino M,
et al. Protein Kinase CK2 Inhibition Represents a Pharmacological Chance for the Treatment of Skin Diseases. International Journal of Molecular Sciences. 2025; 26(11):5404.
https://doi.org/10.3390/ijms26115404
Chicago/Turabian Style
Scuruchi, Michele, Desirèe Speranza, Giuseppe Bruschetta, Federico Vaccaro, Mariarosaria Galeano, Giovanni Pallio, Mario Vaccaro, Francesco Borgia, Federica Li Pomi, Massimo Collino,
and et al. 2025. "Protein Kinase CK2 Inhibition Represents a Pharmacological Chance for the Treatment of Skin Diseases" International Journal of Molecular Sciences 26, no. 11: 5404.
https://doi.org/10.3390/ijms26115404
APA Style
Scuruchi, M., Speranza, D., Bruschetta, G., Vaccaro, F., Galeano, M., Pallio, G., Vaccaro, M., Borgia, F., Li Pomi, F., Collino, M., & Irrera, N.
(2025). Protein Kinase CK2 Inhibition Represents a Pharmacological Chance for the Treatment of Skin Diseases. International Journal of Molecular Sciences, 26(11), 5404.
https://doi.org/10.3390/ijms26115404
